Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Document Type
Year range
1.
Orv Hetil ; 161(17): 689-691, 2020 04 01.
Article in Hungarian | MEDLINE | ID: covidwho-211546

ABSTRACT

Hydroxychloroquine is an immunomodulatory drug that has been used to treat malaria and autoimmune diseases such as systemic lupus erythematosus and inflammatory arthritis. The authors conclude the proarrhytmic effects of hydroxychloroquine and the most important signs of drug-induced long QT syndrome. This article is especially relevant and timely due to the more frequent (currently not evidence-based) use of the drug during the 2019­2020 coronavirus pandemic. Orv Hetil. 2020; 161(17): 689­691.


Subject(s)
Antiviral Agents , Coronavirus Infections/drug therapy , Coronavirus , Hydroxychloroquine/adverse effects , Long QT Syndrome , Pneumonia, Viral/drug therapy , Antimalarials/adverse effects , Antimalarials/therapeutic use , Antiviral Agents/adverse effects , Antiviral Agents/therapeutic use , Betacoronavirus , COVID-19 , Electrocardiography , Humans , Hydroxychloroquine/therapeutic use , Long QT Syndrome/chemically induced , Pandemics , Risk , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL